Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
Clinical trial NCT04480814 · COMPLETED
Trial details
- NCT number
- NCT04480814
- Sponsor
- Pharmassist Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-11
- Primary completion
- 2022-02-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.